ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(10.1%),Van Herk Investments THI B.V.(10.1%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Van Herk Investments B.V.(8.8%),Van Herk Investments THI B.V.(8.8%), etc.
ProQR Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Van Herk Investments B.V.(5.3%),Van Herk Investments THI B.V.(5.3%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(0%),Roderick Wong(0%)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Patrick Johan Hendrik Krol(7.6%),Privium Fund Management B.V.(7.5%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(4.49%),Adage Capital Partners GP, L.L.C.(4.49%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals(Amendment)-GOLDMAN SACHS & CO. LLC(0.0 %),THE GOLDMAN SACHS GROUP, INC.(0.0 %)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Eli Lilly and Company(16.6%)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(0.00%),Wellington Group Holdings LLP(0.00%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RTW Investments, LP(9.9%),Roderick Wong(9.9%)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adage Capital Partners, L.P.(6.63%),Adage Capital Partners GP, L.L.C.(6.63%), etc.
ProQR Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-FMR LLC(6.271%),Abigail P. Johnson(6.271%)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-THE GOLDMAN SACHS GROUP, INC.(5.6 %),GOLDMAN SACHS & CO. LLC(5.6 %)
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Patrick Johan Hendrik Krol(6.8%),Stichting Aescap Life Sciences(6.7%), etc.
ProQR Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Wellington Management Group LLP(5.65%),Wellington Group Holdings LLP(5.65%), etc.
ProQR Therapeutics | SC 13G: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions
ProQR Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
ProQR Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
ProQR Therapeutics | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
No Data
No Data